Description
Specifications
| Form | Lyophilized powder, single vial |
| Contents | GHK-Cu 50 mg · KPV 20 mg |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| GHK-Cu | C₁₄H₂₂CuN₆O₄ · MW 401.9 · CAS 89030-95-5 |
| KPV | C₁₆H₃₀N₄O₄ · MW 342.4 · CAS 67727-97-3 |
How Is This Blend Studied?
This blend pairs two short peptides studied for complementary roles in tissue remodeling and inflammatory signaling. GHK-Cu, the copper(II) complex of glycyl-L-histidyl-L-lysine first isolated from human plasma in 1973, has been studied in animal and cell-culture models for collagen and glycosaminoglycan synthesis, new blood vessel formation and regulation of genes involved in tissue remodeling. KPV (Lys-Pro-Val), the C-terminal tripeptide of alpha-MSH, is studied for anti-inflammatory activity, including uptake through the intestinal PepT1 transporter and modulation of NF-κB and MAPK signaling. Together they let researchers study remodeling and inflammation-control pathways side by side.
Storage
Store the sealed vial at −20 °C for long-term storage, or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and don’t freeze it. See our storage guide.
FAQ
How is this different from KLOW?
KLOW also contains BPC-157 and TB-500. This blend pairs GHK-Cu and KPV on their own, with more KPV.
Is a Certificate of Analysis available?
Yes. Every lot is third-party tested, and the current lot’s COA is posted on this page.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
